Actually, NVS has ample production capacity for Lovenox. The claim that it doesn’t is misdirection by NVS and MNTA to thwart an authorized generic by SNY.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”